Calidi Biotherapeutics (CLDI) has provided an announcement.
Calidi Biotherapeutics, Inc. has announced the launch of its new subsidiary, Redtail Biopharma, Inc., and has shared a presentation on its website for public viewing. While the company has reported this information to comply with regulatory requirements, it does not imply the information’s significance. The presentation details are not intended for legal liability or for integration into future securities filings.
For detailed information about CLDI stock, go to TipRanks’ Stock Analysis page.
